Personal Results and Dosing Strategies for GLOW vs KLOW Peptide Blends (KPV, BPC-157, TB500, GHK-Cu)

The Enhanced Man

GLOW & KLOW Differences and Personal Protocol [0:00]

The speaker shares personal results and dosing strategies for GLOW and KLOW peptide blends, which include KPV, BPC-157, TB500, and GHK-Cu.

• Previous KLOW Cycle and Injury Background [0:16]

  • The speaker completed a 10-day intense KLOW cycle on February 14th, following a persistent back injury from June 2025, re-triggered in October.
  • Initial recovery from the injury was partial, necessitating continued peptide use.
  • An epigenetic test was performed on February 16th to assess long-term inflammation trends.

    

  • CRP and DNA Methylation: C-Reactive Protein (CRP) is produced by the liver in response to acute inflammation, and DNAm CRP provides a stable, long-term measure of chronic inflammation.

    

• Intense 10-Day Cycle Dosing [0:50]

  • The KLOW blend was an 80mg vial, meaning 1mg/day of BPC-157, TB500, and KPV, and 5mg/day of GHK-Cu.
  • These doses are higher than typical advised ranges, suitable for post-surgery or intense athletic events over a short period.
  • Long-term biological processes like angiogenesis and extracellular matrix remodeling require more than 10 days for optimal results.

• Chronic Inflammation Markers Improvement [1:44]

  • C-Reactive Protein (CRP): Improved significantly to the 10.1 percentile by November, remaining constant despite re-triggered injuries, indicating consistent positive lifestyle choices.

    

  • Interleukin-6 (IL-6): Historically a weak area, it dropped from the 96th percentile in June 2023 to the best-ever 63rd percentile.

    

  • Inflammation Age: Using True Diagnostics Symphony Age clock (updated in November to be more sensitive), the speaker shaved off 3.6 years of inflammation age since November.

    

    

• Current GLOW Cycle and Dosing [4:15]

  • The speaker extended the GLOW cycle to over 20 days for better ROI, despite initial concerns about peptide degradation.
  • Research indicates minimal degradation (1.1% over 28 days) for combined peptides if stored properly away from direct sunlight.

    

  • Current daily dosing: 2.5mg GHK-Cu and 500mcg each of BPC-157 and TB500, often with a couple of days off.
  • Injections are done in the evening to avoid interfering with post-exercise pro-inflammatory signals, but GHK-Cu can cause stinging that may disrupt sleep if taken too close to bedtime.

    

KPV and GHK-Cu Results [6:47]

The speaker discusses specific results observed from KPV and GHK-Cu.

• KPV Efficacy (Oral vs. Injectable) [6:47]

  • No significant difference was noted between intense 10-day cycles of KPV in GLOW or KLOW stacks.
  • Oral KPV, taken for 30 days, showed positive results in gut inflammation.
  • Research on KPV and its effectiveness orally in mice.

    

  • Myeloperoxidase (MO) Marker: A 7% drop between July and November, challenging the notion that oral KPV is ineffective.
  • Phenylacetylglutamine (PAG) Marker: An indicator of gut inflammation often seen in weight training individuals on high-protein diets, improved by 3.2% as of February 16th following the injectable KLOW stack.

    

  • Oral KPV capsules were used to target localized effects in the gut.

    

• GHK-Cu Benefits [9:17]

  • GHK-Cu plays a crucial role in extracellular matrix remodeling, collagen synthesis, and maturation, making longer cycles more cost-effective.
  • Injections provide systemic effects, upregulating collagen and elastin synthesis throughout the body, not just localized areas.
  • The Dunedin PACE test, which assesses the pace of aging, correlates highly with quality of life metrics and facial aging.

    

  • Anecdotal evidence suggests GHK-Cu helps tighten skin after weight loss and with aging.
  • Topical GHK-Cu serum was used to further enhance skin benefits.

    

  • Skin Elasticity: Improved marginally by 2% over the last year, a difficult metric to change.
  • Skin Barrier Integrity: Increased by 12% from February 2025 to 2026, attributed primarily to topical 3.3% GHK-Cu serum used for 60 days straight, with a possible association with the GLOW stack.

    

  • Skin hydration also remained excellent, even late in the day, indicating improved ability to retain moisture.

Are Blends Better? [11:49]

The convenience of peptide blends is highlighted for new users.

• Convenience for Beginners
  • Blends simplify the process of peptide therapy, as common peptides like TB500, BPC-157, and GHK-Cu are often used together.
  • Reconstituting multiple peptides can be intimidating for new users, potentially leading to waste.
  • Simplicity is crucial for increasing accessibility to peptides.
  • Sourcing peptides from reputable suppliers, like Peptides of London, is essential for purity and sterility to avoid adverse reactions like injection site inflammation.

    

    

  • Another example of a blend product from Swiss Chems was mentioned.

    

KLOW Recovery Results [13:17]

Wearable tech data confirmed physiological improvements during the KLOW cycle.

• Whoop Data Analysis
  • Tracking heart rate variability (HRV) with wearables provides short-term insights into physiological functioning when introducing new compounds.
  • Using AI (e.g., ChatGPT) to triangulate raw data from wearables can help identify correlations.
  • During the 10-day intense KLOW cycle, the speaker's HRV increased by 3.72 milliseconds, indicating improved heart contractility under stress.

    

  • Recovery scores improved by nearly 10.5%, despite a slight decrease in sleep performance and increased training intensity (strength up by 0.87).
  • This suggests the peptides enhanced recovery even with higher physical demands.

Injury Prevention [15:44]

Strategies for preventing inflammation and managing back pain.

• Managing Back Inflammation
  • The speaker focuses on maintaining low C-reactive protein (CRP) levels and optimizing Interleukin-6 (IL-6) to the 5th percentile (not too low to avoid immune suppression).
  • Lifestyle adjustments are prioritized over peptide reliance for long-term health.
  • Key Preventative Measures:
    • Maintaining good technique during gym workouts.
    • Regular back stretching, especially after prolonged sitting.

      

    • Avoiding uncomfortable prolonged seating arrangements.
    • Strategies for long car journeys (e.g., rotating seating positions).
  • Significant improvement: No deep tissue massages have been required since autumn last year, indicating better pain management and reduced severity.